查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球複合藥房市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342731

全球複合藥房市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Compounding Pharmacies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 232 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2030 年，全球複合藥房市場的市場規模將從 2022 年的 144.4 億美元達到近 282.3 億美元，2023-2030 年研究期間年複合成長率為 8.74%。

配製藥房是獲得定製藥物的安全可靠的方式。複合藥房是特定類型的藥房。復配藥房是根據市售藥物無法滿足的特定患者的需要，為特定患者配製醫生處方的藥物。複合藥房可以根據患者的喜好和限制創建定製劑型。複合藥房只會發行通過醫生處方獲得的藥物。調配藥房會接受額外的品質評估，以向消費者保證產品已按照調配標准進行調配。

市場動態

癌症等慢性疾病變得越來越普遍，隨著複合藥房資金的增加，將在預測期內提振市場。此外，藥品短缺也是該地區復方藥店成長的一個重要原因。此外，人們對複合藥物益處的認知不斷增強，將導致此類個性化藥物的使用量增加，並導致市場成長。主要市場參與者在研發方面的投資激增，以創新和定製配方以有效治療各種疾病，預計將推動複方藥房市場的成長。然而，對製造複雜配方的限制增加可能會阻礙市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球複合藥房市場的每個細分市場進行了包容性評估。複合製藥行業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲複合藥房市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。複合藥房市場的主要參與者包括 Fagron、B. Braun、Nephron Pharmaceuticals Corporation、Fresenius Kabi、Athenex Pharma Solutions (Athenex Inc.)、Dougherty's Pharmacy, Inc.、Clinigen Group PLC、Pencol Complexing Pharmacy、Lorraine's Pharmacy、McGuff Company Inc .（McGuff 複合藥房服務）、Institutional Pharmacy Solutions、Rx3 複合藥房、Wedgewood Village Pharmacy, Inc. 和Triangle 複合藥房。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：複合藥劑 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按治療領域分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：按應用分類
    • 按複利類型進行的市場吸引力分析
    • 按不育性進行市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球複方藥市場分析：按治療領域

  • 按治療領域概述
  • 歷史和預測數據
  • 按治療領域分析
  • 皮膚科
  • 疼痛管理
  • 特殊藥物
  • 營養補充劑
  • 激素替代品
  • 其他

第 7 章：全球複合製藥市場分析：按產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 口服（固體製劑、液體製劑）
  • 局部用藥（霜劑、凝膠劑、軟膏劑、糊劑、其他
  • 直腸（灌腸劑、栓劑、其他）
  • 腸外注射（LVP、SVP）
  • 眼科
  • 鼻腔
  • 奧迪克

第 8 章：全球複合藥房市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 兒科
  • 老年科
  • 成人
  • 獸醫

第 9 章：全球複方藥房市場分析：按複方類型

  • 按複合類型概述
  • 歷史和預測數據
  • 按複合類型分析
  • 藥物劑量變更 (PDA)
  • 藥物成分變更 (PIA)
  • 目前不可用的藥品製造 (CUPM)
  • 其他

第 10 章：全球複合藥房市場分析：按無菌度

  • 無菌概述
  • 歷史和預測數據
  • 無菌分析
  • 非無菌
  • 無菌

第 11 章：全球複合藥房市場分析：按配銷通路

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 複方藥劑
  • 醫院藥房
  • 其他

第 12 章：全球複合藥房市場銷售分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 13 章：複方製藥公司的競爭格局

  • 複合藥房市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 14 章：公司簡介

  • 頂級公司股票分析
  • 市場集中度
  • Fagron
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • B. Braun
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nephron Pharmaceuticals Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Fresenius Kabi
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Athenex Pharma Solutions (Athenex Inc.)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dougherty's Pharmacy Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Clinigen Group PLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pencol Compounding Pharmacy
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lorraine's Pharmacy
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • McGuff Company Inc. (McGuff Compounding Pharmacy Services)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Institutional Pharmacy Solutions
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Rx3 Compounding Pharmacy
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Wedgewood Village Pharmacy Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Triangle Compounding Pharmacies
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR11219448

The global demand for Compounding Pharmacies Market is presumed to reach the market size of nearly USD 28.23 BN by 2030 from USD 14.44 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

Compounding pharmacies are a safe and reliable way to receive customized medications. Compounding pharmacies are specific types of pharmacies. Compounding pharmacies are to make drugs prescribed by doctors for specific patients with needs that commercially available drugs cannot meet. Compounding pharmacies can create customized dosage forms based on patient preferences and restrictions. Compounding pharmacies will only issue those medications obtained via a doctor's prescription. Compounding pharmacies undergo an extra quality assessment to assure consumers that the product has been compounded to compounding standards.

MARKET DYNAMICS

The chronic diseases such as cancer are becoming more common along with increasing funding for compounding pharmacies will boost the market over the forecast period. Also, the shortage of drugs is a strong reason for the growth of compounding pharmacies across the region. Moreover, the growing awareness about the benefits of compounded medications will lead to higher use of such personalized medications and result in market growth. The surging investments by the key market players in research and development to innovate and customize the formulations to effectively treat various diseases are expected to boost the growth of the compounding pharmacies market. However, increased restrictions on manufacturing complex formulations may hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of compounding pharmacies. The growth and trends of compounding pharmacies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the compounding pharmacies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutic Area

  • Dermatology
  • Pain Management
  • Specialty Drugs
  • Nutritional Supplements
  • Hormone Replacement
  • Others

By Product

  • Oral (Solid Preparations, Liquid Preparations)
  • Topical (Creams, Gels, Ointments, Pastes, Others
  • Rectal (Enema, Suppositories, Others)
  • Parenteral (LVP, SVP)
  • Ophthalmic
  • Nasal
  • Otic

By Application

  • Pediatric
  • Geriatric
  • Adult
  • Veterinary

By Compounding Type

  • Pharmaceutical Dosage Alteration (PDA)
  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

By Sterility

  • Non-Sterile
  • Sterile

By Distribution Channel

  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Compounding Pharmacies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the compounding pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty's Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc. and Triangle Compounding Pharmacies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . COMPOUNDING PHARMACIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Compounding Type
    • 3.7.5 Market Attractiveness Analysis By Sterility
    • 3.7.6 Market Attractiveness Analysis By Distribution Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1 Overview by Therapeutic Area
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapeutic Area
  • 6.4 Dermatology Historic and Forecast Sales by Regions
  • 6.5 Pain Management Historic and Forecast Sales by Regions
  • 6.6 Specialty Drugs Historic and Forecast Sales by Regions
  • 6.7 Nutritional Supplements Historic and Forecast Sales by Regions
  • 6.8 Hormone Replacement Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Oral (Solid Preparations, Liquid Preparations) Historic and Forecast Sales by Regions
  • 7.5 Topical (Creams, Gels, Ointments, Pastes, Others Historic and Forecast Sales by Regions
  • 7.6 Rectal (Enema, Suppositories, Others) Historic and Forecast Sales by Regions
  • 7.7 Parenteral (LVP, SVP) Historic and Forecast Sales by Regions
  • 7.8 Ophthalmic Historic and Forecast Sales by Regions
  • 7.9 Nasal Historic and Forecast Sales by Regions
  • 7.10. Otic Historic and Forecast Sales by Regions

8 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Pediatric Historic and Forecast Sales by Regions
  • 8.5 Geriatric Historic and Forecast Sales by Regions
  • 8.6 Adult Historic and Forecast Sales by Regions
  • 8.7 Veterinary Historic and Forecast Sales by Regions

9 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY COMPOUNDING TYPE

  • 9.1 Overview by Compounding Type
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Compounding Type
  • 9.4 Pharmaceutical Dosage Alteration (PDA) Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical Ingredient Alteration (PIA) Historic and Forecast Sales by Regions
  • 9.6 Currently Unavailable Pharmaceutical Manufacturing (CUPM) Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY STERILITY

  • 10.1 Overview by Sterility
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Sterility
  • 10.4 Non-sterile Historic and Forecast Sales by Regions
  • 10.5 Sterile Historic and Forecast Sales by Regions

11 . GLOBAL COMPOUNDING PHARMACIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 11.1 Overview by Distribution Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Distribution Channel
  • 11.4 Compounding Pharmacy Historic and Forecast Sales by Regions
  • 11.5 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 11.6 Others Historic and Forecast Sales by Regions

12 . GLOBAL COMPOUNDING PHARMACIES MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE COMPOUNDING PHARMACIES COMPANIES

  • 13.1. Compounding Pharmacies Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF COMPOUNDING PHARMACIES INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Fagron
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. B. Braun
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Nephron Pharmaceuticals Corporation
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Fresenius Kabi
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Athenex Pharma Solutions (Athenex Inc.)
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Dougherty's Pharmacy Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Clinigen Group PLC
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Pencol Compounding Pharmacy
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. Lorraine's Pharmacy
    • 14.11.1. Company Overview
    • 14.11.2. Company Revenue
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. McGuff Company Inc. (McGuff Compounding Pharmacy Services)
    • 14.12.1. Company Overview
    • 14.12.2. Company Revenue
    • 14.12.3. Products
    • 14.12.4. Recent Developments
  • 14.13. Institutional Pharmacy Solutions
    • 14.13.1. Company Overview
    • 14.13.2. Company Revenue
    • 14.13.3. Products
    • 14.13.4. Recent Developments
  • 14.14. Rx3 Compounding Pharmacy
    • 14.14.1. Company Overview
    • 14.14.2. Company Revenue
    • 14.14.3. Products
    • 14.14.4. Recent Developments
  • 14.15. Wedgewood Village Pharmacy Inc.
    • 14.15.1. Company Overview
    • 14.15.2. Company Revenue
    • 14.15.3. Products
    • 14.15.4. Recent Developments
  • 14.16. Triangle Compounding Pharmacies
    • 14.16.1. Company Overview
    • 14.16.2. Company Revenue
    • 14.16.3. Products
    • 14.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Compounding Pharmacies Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Compounding Pharmacies Report
  • Market Research Process
  • Market Research Methodology
  • Global Compounding Pharmacies Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Compounding Type
  • Market Attractiveness Analysis by Sterility
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Dermatology Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Specialty Drugs Market Sales by Geography (USD MN)
  • Nutritional Supplements Market Sales by Geography (USD MN)
  • Hormone Replacement Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Oral (Solid Preparations, Liquid Preparations) Market Sales by Geography (USD MN)
  • Topical (Creams, Gels, Ointments, Pastes, Others Market Sales by Geography (USD MN)
  • Rectal (Enema, Suppositories, Others) Market Sales by Geography (USD MN)
  • Parenteral (LVP, SVP) Market Sales by Geography (USD MN)
  • Ophthalmic Market Sales by Geography (USD MN)
  • Nasal Market Sales by Geography (USD MN)
  • Otic Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Geriatric Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Veterinary Market Sales by Geography (USD MN)
  • Global Market Analysis by Compounding Type (USD MN)
  • Pharmaceutical Dosage Alteration (PDA) Market Sales by Geography (USD MN)
  • Pharmaceutical Ingredient Alteration (PIA) Market Sales by Geography (USD MN)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Sterility (USD MN)
  • Non-sterile Market Sales by Geography (USD MN)
  • Sterile Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Compounding Pharmacy Market Sales by Geography (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.